Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pulmonology · Chronic Pulmonary Aspergillosis

How Do Lung Diseases Raise Aspergillus niger Risk?

At a Glance

COPD, emphysema, bronchiectasis, and prior tuberculosis can damage lung structure and raise the risk of chronic Aspergillus disease, but a positive Aspergillus niger sputum culture may only show harmless colonization. Symptoms, CT changes, and blood tests help determine whether treatment is needed.

If you have structural lung disease—conditions that have permanently changed the architecture of your lungs, such as chronic obstructive pulmonary disease (COPD), emphysema, bronchiectasis, or a history of tuberculosis—your risk for chronic Aspergillus infections is higher. While Aspergillus fumigatus is the most common cause, Aspergillus niger can also be involved.

However, finding A. niger in your sputum (phlegm) does not automatically mean you have an active infection. Because these fungi are common in the environment, they can temporarily land in your airways or live there without causing harm, a state known as colonization [1][2]. A true infection, such as chronic pulmonary aspergillosis (CPA), requires medical evaluation and develops when the fungus takes advantage of pre-existing lung damage [3][4].

What This Means For You: A positive A. niger culture is just a finding. Your clinician will determine whether it is harmless colonization or active disease by evaluating your symptoms, CT scan changes, and additional test results.

How Lung Damage Invites Infection

Healthy lungs have smooth airways and robust defense mechanisms that clear out inhaled fungal spores. Underlying lung conditions alter this environment, creating spaces where Aspergillus niger can persist and grow:

  • Cavities and Scarring: Prior tuberculosis or severe lung infections can leave behind empty spaces (cavities) or areas of fibrosis (permanent lung scarring) [3][5]. Aspergillus spores can settle into these sheltered cavities and sometimes grow into a tangled mass known as a fungal ball (aspergilloma) [6].
  • Enlarged Air Spaces: Emphysema destroys the delicate air sacs in the lungs, creating abnormally large, damaged spaces where the fungus can more easily take hold [3][7].
  • Impaired Mucus Clearance: Bronchiectasis causes airways to become permanently widened and weakened. This damage impairs your lungs’ ability to clear mucus, allowing fungal spores to become trapped in the airways [8][9].

Additionally, the treatments often used for these conditions can affect your risk. Systemic corticosteroids (steroid pills or IVs) and high-dose inhaled steroids suppress your immune system, while repeated courses of antibiotics alter the balance of microbes in your airways [10][11]. Important: Never stop or change your corticosteroid medications without your doctor’s supervision, as abrupt changes can be dangerous [12].

Understanding the Different Stages

A positive A. niger culture can mean several different things depending on your specific situation:

Stage What It Is Typical Signs What It Means
Colonization The fungus lives in the airways but isn’t causing disease [1]. No new symptoms; no new CT changes. Often requires no antifungal treatment, just observation [1].
Aspergilloma A “fungal ball” growing inside an existing lung cavity [6]. May cause no symptoms, or can cause coughing up blood [4]. May just be monitored, or might require treatment if it causes bleeding.
Chronic Pulmonary Aspergillosis (CPA) A slow-moving, active infection damaging the lung tissue [3]. Worsening cough, weight loss, fatigue, new cavities or nodules on CT [13]. Requires specialist review and often long-term oral antifungal medication [4].

Diagnosing Active Infection (CPA)

Unlike acute infections, CPA develops gradually over months or years [13]. Because symptoms overlap with your baseline COPD or bronchiectasis, separating fungal symptoms from your usual baseline can be stressful. Your doctor is looking for specific changes from your normal health. Diagnosis involves a combination of factors:

  • Symptoms: A compatible illness lasting for months. Symptoms might include a worsening chronic cough, breathlessness, unexplained weight loss, fatigue, fever, or chest pain [7][14].
  • Imaging: A chest CT scan showing progressive cavities, fungal balls, nodules, pleural thickening, or pericavitary infiltrates [4][13].
  • Blood Tests: An Aspergillus IgG blood test looks for antibodies to see if your immune system is actively fighting the fungus. While a positive result supports the diagnosis, it does not absolutely prove active infection (it can reflect past exposure), and a negative result doesn’t completely rule it out [3][15].

A Warning on Coughing Up Blood (Hemoptysis)

Coughing up blood can be a symptom of CPA, an aspergilloma, or your underlying bronchiectasis [4][14].
Emergency Action: If you experience increasing or persistent bleeding, cough up more than small streaks (e.g., clots or larger amounts), or if the bleeding is accompanied by severe breathlessness, dizziness, fainting, or chest pain, seek emergency medical care immediately [4]. Even small, recurrent amounts of blood should be reported promptly to your care team.

Next Steps and Supporting Your Lungs

If A. niger is found and your doctor suspects active disease, you will likely be referred to a respiratory or infectious disease specialist. If CPA is diagnosed, treatment often involves prolonged oral antifungal therapy, which requires regular monitoring for drug interactions and liver function [4][16].

While you cannot entirely prevent Aspergillus exposure, you can support your general lung health. These measures won’t cure or guarantee prevention of a fungal infection, but they help manage your underlying disease:

  • Medication Review: Have your doctor review your need for corticosteroids and antibiotics to ensure the benefits outweigh the risks [12][11].
  • Airway Clearance: If you have bronchiectasis, regularly clearing mucus reduces exacerbations [17]. Use bronchodilators (inhalers that relax and open airways) as prescribed.
  • General Health: Quitting smoking and getting vaccinated (like flu, pneumococcal, and COVID-19 vaccines) helps prevent other respiratory illnesses that could further damage your lungs [5][12].

Common questions in this guide

Can COPD, emphysema, bronchiectasis, or past tuberculosis increase Aspergillus risk?
Yes—these conditions can leave cavities or scarring, weaken or enlarge airways, and reduce mucus clearance, making it easier for Aspergillus spores to remain in the lungs. Increased risk does not mean that an active infection is present.
Does finding Aspergillus niger in sputum mean I have a lung infection?
No. A sputum culture can show colonization, meaning the fungus is present without causing disease. Doctors consider new or worsening symptoms, chest CT changes, and other test results before diagnosing active pulmonary aspergillosis.
How do doctors diagnose chronic pulmonary aspergillosis?
Doctors combine symptoms that persist or worsen over months with CT findings such as new cavities, nodules, or a fungal ball. An Aspergillus IgG blood test can support the diagnosis, but a positive result may reflect past exposure and a negative result does not completely rule it out.
What is the difference between Aspergillus colonization, an aspergilloma, and CPA?
Colonization means Aspergillus is present in the airways without causing disease. An aspergilloma is a fungal ball in an existing lung cavity, while chronic pulmonary aspergillosis is a slowly active infection that damages lung tissue. Management may range from observation to specialist treatment, depending on symptoms, scans, and test results.
When is coughing up blood from a lung problem an emergency?
Seek emergency care for more than small streaks, clots, or increasing or persistent bleeding, especially with severe breathlessness, dizziness, fainting, or chest pain. Even small amounts of blood that recur should be reported promptly to your care team.
Should I stop my steroid medicine if Aspergillus is found?
Do not stop or change corticosteroids on your own, because sudden changes can be dangerous. Ask your clinician to review the dose and whether the benefits outweigh the risks, along with any antibiotic use.
What treatment might be needed for chronic pulmonary aspergillosis?
Chronic pulmonary aspergillosis often requires prolonged oral antifungal medicine. Treatment usually includes specialist follow-up and monitoring for drug interactions and liver problems, and the plan depends on symptoms, scans, and test results.

Get notified when new evidence is published on Aspergillus niger infection.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    [Aspergillus in airway material : Ignore or treat?]

    Salzer HJF, Lange C, Hönigl M

    Der Internist 2017; (58(11)):1150-1162 doi:10.1007/s00108-017-0334-9.

    PMID: 28986661
  2. 2

    Non-fumigatus Aspergillus-associated pulmonary events: a diagnostic challenge.

    Godet C, Joste V, Frat J-P, et al.

    Journal of clinical microbiology 2026; (64(4)):e0016326 doi:10.1128/jcm.00163-26.

    PMID: 41848336
  3. 3

    Chronic Pulmonary Aspergillosis: Clinical Presentation and Management.

    Evans TJ, Lawal A, Kosmidis C, Denning DW

    Seminars in respiratory and critical care medicine 2024; (45(1)):88-101 doi:10.1055/s-0043-1776914.

    PMID: 38154471
  4. 4

    Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.

    Denning DW, Cadranel J, Beigelman-Aubry C, et al.

    The European respiratory journal 2016; (47(1)):45-68 doi:10.1183/13993003.00583-2015.

    PMID: 26699723
  5. 5

    Secondary infections following tuberculosis: epidemiology, pathogenesis and clinical implications.

    Cortacans M, Gogichadze N, Soldevilla P, et al.

    Breathe (Sheffield, England) 2026; (22(1)):250055 doi:10.1183/20734735.0055-2025.

    PMID: 41607634
  6. 6

    Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.

    Hedayati MT, Azimi Y, Droudinia A, et al.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2015; (34(9)):1759-65 doi:10.1007/s10096-015-2409-7.

    PMID: 26003310
  7. 7

    Clinical Features, Diagnostic Test Performance, and Prognosis in Different Subtypes of Chronic Pulmonary Aspergillosis.

    Zhong H, Wang Y, Gu Y, et al.

    Frontiers in medicine 2022; (9()):811807 doi:10.3389/fmed.2022.811807.

    PMID: 35223906
  8. 8

    Bronchiectasis complicated by pulmonary aspergillosis: a multicenter study on prognosis and risk factors.

    Yang J, Wang X, Lu S, et al.

    Journal of thoracic disease 2025; (17(11)):9827-9835 doi:10.21037/jtd-2025-1139.

    PMID: 41376918
  9. 9

    Aspergillus-Associated Endophenotypes in Bronchiectasis.

    Jaggi TK, Ter SK, Mac Aogáin M, Chotirmall SH

    Seminars in respiratory and critical care medicine 2021; (42(4)):556-566 doi:10.1055/s-0041-1730947.

    PMID: 34261180
  10. 10

    The emergence of Aspergillus species in chronic respiratory disease.

    Yii AC, Koh MS, Lapperre TS, et al.

    Frontiers in bioscience (Scholar edition) 2017; (9(1)):127-138 doi:10.2741/s477.

    PMID: 27814579
  11. 11

    COPD and Aspergillus-a complex interaction of global health importance.

    Denning DW, Bertuzzi M, Chotirmall SH, et al.

    The Lancet. Infectious diseases 2026; doi:10.1016/S1473-3099(26)00360-9.

    PMID: 42612667
  12. 12

    Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.

    Denning DW, Rogers TR, Takazono T, et al.

    American journal of respiratory and critical care medicine 2026; doi:10.1093/ajrccm/aamag310.

    PMID: 42384914
  13. 13

    Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings.

    Denning DW, Page ID, Chakaya J, et al.

    Emerging infectious diseases 2018; (24(8)) doi:10.3201/eid2408.171312.

    PMID: 30016256
  14. 14

    Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients.

    Hou X, Zhang H, Kou L, et al.

    Medicine 2017; (96(42)):e8315 doi:10.1097/MD.0000000000008315.

    PMID: 29049239
  15. 15

    Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species-Specific IgG.

    Sehgal IS, Agarwal R, Muthu V, et al.

    Mycoses 2025; (68(9)):e70107 doi:10.1111/myc.70107.

    PMID: 40899055
  16. 16

    Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease.

    Phoompoung P, Chayakulkeeree M

    Journal of fungi (Basel, Switzerland) 2020; (6(4)) doi:10.3390/jof6040346.

    PMID: 33302348
  17. 17

    Interventions to reduce the impact of post-tuberculosis lung disease: a scoping review of the literature.

    Byrne AL, Günther G, Tadyanemhandu C, et al.

    BMC pulmonary medicine 2026; (26(1)).

    PMID: 42243811

This page is for informational purposes only and does not constitute medical advice. Ask your respiratory or infectious disease clinician to interpret your symptoms, test results, and scans and guide your treatment.